Access to medications for opioid use disorder is limited in part due to minimal provider knowledge about treatment options, including extended-release naltrexone. Adequate understanding among providers and patients of the risks involved with extended release naltrexone contribute to lower rates of retention in care on this medication compared to other forms of MOUD. Significant...

Faculty

• Devin A. Oller , MD, FACO, FASAM

Access to medications for opioid use disorder is limited in part due to minimal provider knowledge about treatment options, including extended-release naltrexone. Adequate understanding among providers and patients of the risks involved with extended release naltrexone contribute to lower rates of retention in care on this medication compared to other forms of MOUD. Significant...

Faculty

• Devin A. Oller , MD, FACO, FASAM

Medications for Opioid Use Disorder (MOUD) are an effective but underutilized treatment that can save lives and improve quality of life for patients with OUD. Despite the evidence that MOUD save lives, behavioral interventions are often used alone in a treatment plan or as a requirement to gain access to MOUD. Understanding behavioral interventions in the treatment of OUD and as a...

Faculty

• Devin A. Oller , MD, FACO, FASAM
• Liza B. Bastin , MD

Individuals with substance use disorders often face barriers to seeking sustainable resources to improve their recovery capital.  Transition between care settings presents vulnerabilities to individuals with SUD who are seeking resources

Faculty

• Emily Sprouse , CSW
• McKenzie Clarke , LSW
• Linda G. Edwards , CADC

Individuals with substance use disorders often face barriers to seeking sustainable resources to improve their recovery capital.  Transition between care settings presents vulnerabilities to individuals with SUD who are seeking resources

Faculty

• Emily Sprouse , CSW
• McKenzie Clarke , LSW
• Linda G. Edwards , CADC

Overdose deaths per 100,000 people occur at a higher rate with the Black/Non-Hispanic and American Indian, Alaska Natives than with White/Non-Hispanic group.  Culturally responsive services are crucial to address disparities in access and perceived benefit for addiction treatment in marginalized communities

Faculty

• Fabiola Arbelo-Cruz , MD

Overdose deaths per 100,000 people occur at a higher rate with the Black/Non-Hispanic and American Indian, Alaska Natives than with White/Non-Hispanic group.  Culturally responsive services are crucial to address disparities in access and perceived benefit for addiction treatment in marginalized communities

Faculty

• Fabiola Arbelo-Cruz , MD

Patients with opioid use disorder have a disability that is protected by the Americans with Disabilities Act (ADA), yet few patient care providers or patients are aware of what the protections are or how to file a case for an ADA violation. This talk will serve as a primer to explain how to...

Faculty

• Anna-Maria South , MD

Patients with opioid use disorder have a disability that is protected by the Americans with Disabilities Act (ADA), yet few patient care providers or patients are aware of what the protections are or how to file a case for an ADA violation. This talk will serve as a primer to explain how to...

Faculty

• Anna-Maria South , MD

Individuals with OUD need more treatment options that can address problems such as: nonadherence, medication misuse/diversion/theft, access to care, and transportation limitations. Injectable m Michelle R. Lofwall , MD, DFASAM

Faculty

• Rachel V. Smith , MPH, CPH